Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Repeated Low-Level Red-Light Therapy in Dry Age-Related Macular Degeneration: A Randomized Controlled Trial

NCT07409389 is registered in ClinicalTrials.gov with The Hong Kong Polytechnic University as lead sponsor.

NCT NCT07409389
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07409389 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Repeated Low-Level Red-Light Therapy in Dry Age-Related Macular Degeneration: A Randomized Controlled Trial
Lead sponsor
The Hong Kong Polytechnic University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 26, 2026
Completion date
December 1, 2026
Enrollment
94 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amd - age-related macular degeneration